Status:
COMPLETED
Effect of Glycopyrronium in Combination With Tropisetron in Anti-postoperative Nausea and Vomiting
Lead Sponsor:
The Second Affiliated Hospital of Chongqing Medical University
Collaborating Sponsors:
Chongqing General Hospital
Chongqing Medical University
Conditions:
Postoperative Nausea and Vomiting
Eligibility:
All Genders
18-70 years
Phase:
PHASE4
Brief Summary
To compare the anti-nausea and vomiting effect between glycopyrronium in combination with tropisetron and normal saline in combination with tropisetron for patients receiving elective surgery under ge...
Eligibility Criteria
Inclusion
- Non-cardiac surgery
- American Society of Anesthesiologists classification I-III
- Receive general anesthesia
- Voluntarily receive postoperative intravenous controlled analgesia
Exclusion
- Puerpera or lactation women
- Allergy or existing contraindication to glycopyrronium and tropisetron
- Participate in other clinical drug trials within three months
- Can not follow with the study procedure
Key Trial Info
Start Date :
April 21 2022
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
June 30 2023
Estimated Enrollment :
480 Patients enrolled
Trial Details
Trial ID
NCT05331651
Start Date
April 21 2022
End Date
June 30 2023
Last Update
August 16 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Department of Anesthesiology, The Second Affiliated Hospital, Chongqing Medical University
Chongqing, Chongqing Municipality, China, 400010